Clinical trial Recruiting at 1 site Interventional Ages 30 and up Women only

Helping Latinas access breast cancer care

Official title: Empowering Vulnerable and Resilient Latinas to Obtain Breast Cancer Care

Run by University of Illinois Chicago · NCT05483283 · Data updated 2026-11-12

This study is trying to help Latina women at higher risk for breast cancer by giving them personalized support and education over the phone about breast cancer care, diet, and exercise.

Quick facts

Study typeInterventional
Ages30 Years and up
SexWomen only
Enrollment600 (estimated)
SponsorUniversity of Illinois Chicago
Academic / other
Locations1 site (Chicago, Illinois)
StatusRecruiting
StartedJanuary 18, 2023
Main results expectedSeptember 2027
Study endsSeptember 2027
Registry record updatedMarch 10, 2026
Trial IDNCT05483283 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are Latina women aged 30 and older with a genetic risk factor for breast cancer and a social determinant of health risk.

Probably not a fit

Patients who do not identify as Latina or who have already received genetic counseling or testing may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to empower Latina women at elevated genetic and social risk for breast cancer by providing them with personalized education and support. Participants will engage in three individual phone-based sessions over three weeks, focusing on breast cancer care, diet, and physical activity. The sessions will include testimonials and action plans to address disparities in breast cancer care uptake. Participants will also receive multimedia materials to reinforce the information shared during the sessions.

Why it matters

Potential benefit: If successful, this approach could significantly improve breast cancer care access and outcomes for vulnerable Latina women.

How similar studies have gone: Other studies have shown success in using empowerment and education to improve health outcomes in similar populations, indicating a promising approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Aim 1

1. female biological sex
2. identification as Latina
3. one genetic risk factor (i.e., personal history of breast cancer or family history of breast or ovarian cancer)
4. one SDH risk factor, based on the American Cancer Society's definitions (e.g., perceived financial struggles; transportation difficulties; exposure to violence; housing challenges; social isolation/challenges)
5. 30+ years old, based on American Cancer Society (ACS) screening guidelines for high risk populations
6. No receipt of cancer genetic counseling AND no receipt of genetic testing

Aim 2

1. female biological sex
2. referral from Latina Aim 1 participants
3. eligibility to obtain BC screenings, based on ACS guidelines (e.g., optional annual
4. screenings at 40-44 years old, recommended annual screenings at 45-54 years old, every other year screening at 55 and older)
5. self-report not attending Session #3 (as this will not be recorded by the staff)

Aim 3

1. participant from Aim 1 or
2. participant from Aim 2

Exclusion Criteria:

Aim 1 and Aim 2 Not meeting at least one of the inclusion criteria

Aim 3

1. Not a participant from Aim 1 or
2. Not a participant from Aim 2

Where it's running

  • University of Illinois
    Chicago, Illinois, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.